Narrow search
Showing 1 - 10 of 719
Cover Image
The Economics of Risky Health Behaviors
Cawley, John; Ruhm, Christopher - National Bureau of Economic Research (NBER) - 2011
Risky health behaviors such as smoking, drinking alcohol, drug use, unprotected sex, and poor diets and sedentary lifestyles (leading to obesity) are a major source of preventable deaths. This chapter overviews the theoretical frameworks for, and empirical evidence on, the economics of risky...
Persistent link: https://www.econbiz.de/10009025232
Cover Image
The Impact of Piped Water Provision on Infant Mortality in Brazil: A Quantile Panel Data Approach
Gamper-Rabindran, Shanti; Khan, Shakeeb; Timmins, … - National Bureau of Economic Research (NBER) - 2008
We examine the impact of piped water on the under-1 infant mortality rate (IMR) in Brazil using a novel econometric procedure for the estimation of quantile treatment effects with panel data. The provision of piped water in Brazil is highly correlated with other observable and unobservable...
Persistent link: https://www.econbiz.de/10005248735
Cover Image
Rural Demography, Public Services and Land Rights in Africa: A Village-Level Analysis in Burkina Faso
McMillan, Margaret Mcmillan; Kazianga, Harounan; … - National Bureau of Economic Research (NBER) - 2011
This paper uses historical census data from Burkina Faso to characterize local demographic pressures associated with internal migration into river valleys after Onchocerciasis eradication, combined with a new survey of village elders to document change over time and differences across villages...
Persistent link: https://www.econbiz.de/10009403422
Cover Image
Water Quality Violations and Avoidance Behavior: Evidence from Bottled Water Consumption
Graff Zivin, Joshua; Schlenker, Wolfram; Neidell, Matthew - National Bureau of Economic Research (NBER) - 2011
In this paper, we examine the impact of poor water quality on avoidance behavior by estimating the change in bottled water purchases in response to drinking water violations. Using data from a national grocery chain matched with water quality violations, we find an increase in bottled water...
Persistent link: https://www.econbiz.de/10008788760
Cover Image
Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007
Conti, Rena M.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 2014
estimated prices of these drug undergoing LOE fall with generic entry. Second, we estimate reduced form random effects models of … utilization subsequent to LOE. We observe substantial price erosion after generic entry; average monthly price declines appear to … entry, but this result appears to be largely driven by oral drugs. We discuss second-best welfare consequences of these …
Persistent link: https://www.econbiz.de/10010950850
Cover Image
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity
Kremer, Michael; Snyder, Christopher M. - National Bureau of Economic Research (NBER) - 2013
We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer's ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, revenue...
Persistent link: https://www.econbiz.de/10010951276
Cover Image
The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
Conti, Rena M.; Huskamp, Haiden A.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 2011
The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of medication labeling changes on brand pharmaceutical products, and whether and what firms do to respond to increased information regarding the safety and efficacy...
Persistent link: https://www.econbiz.de/10009325511
Cover Image
The Effect of Medicare Part D on Pharmaceutical Prices and Utilization
Duggan, Mark; Morton, Fiona Scott - National Bureau of Economic Research (NBER) - 2008
On January 1, 2006, the federal government began providing insurance coverage for Medicare recipients' prescription drug expenditures through a new program known as Medicare Part D. Rather than setting pharmaceutical prices itself, the government contracted with private insurance plans to...
Persistent link: https://www.econbiz.de/10005774476
Cover Image
The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing
Duggan, Mark; Morton, Fiona Scott - National Bureau of Economic Research (NBER) - 2004
The federal-state Medicaid program insures 43 million people for virtually all of the prescription drugs approved by the FDA. To determine the price that it will pay for a drug treatment, the government uses the average price in the private sector for that same drug. Assuming that Medicaid...
Persistent link: https://www.econbiz.de/10005778002
Cover Image
Pricing and Reimbursement in U.S. Pharmaceutical Markets
Berndt, Ernst R.; Newhouse, Joseph P. - National Bureau of Economic Research (NBER) - 2010
comment on very recent developments concerning the entry of large retailers such as Wal-Mart into domains traditionally …
Persistent link: https://www.econbiz.de/10008531891